A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

Luca Massimi, Patrick Sin-Chan, Iqra Mumal, Tannu Suwal, Ben Ho, Xiaolian Fan, Irtisha Singh, Yuchen Du, Mei Lu, Neilket Patel, Jonathon Torchia, Dean Popovski, Maryam Fouladi, Paul Guilhamon, Jordan R. Hansford, Sarah Leary, Lindsey M. Hoffman, Jean M. Mulcahy Levy, Alvaro Lassaletta, Palma Solano-PaezEloy Rivas, Alyssa Reddy, G. Yancey Gillespie, Nalin Gupta, Timothy E. Van Meter, Hideo Nakamura, Tai-Tong Wong, Young-Shin Ra, Seung-Ki Kim, Richard G. Grundy, Jason Fangusaro, Donna Johnston, Jennifer Chan, Lucie Lafay-Cousin, Eugene I. Hwang, Yin Wang, Daniel Catchpoole, Jean Michaud, Benjamin Ellezam, Ramya Ramanujachar, Holly Lindsay, Michael D. Taylor, Cynthia E. Hawkins, Eric Bouffet, Nada Jabado, Sheila K. Singh, Claudia L. Kleinman, Dalia Barsyte-Lovejoy, Xiao-Nan Li, Peter B. Dirks, Charles Y. Lin, Stephen C. Mack, Jeremy N. Rich, Annie Huang

Risultato della ricerca: Contributo in rivistaArticolo in rivista

24 Citazioni (Scopus)

Abstract

Embryonal tumors with multilayered rosettes (ETMRs) are highly lethal infant brain cancers with characteristic amplification of Chr19q13.41 miRNA cluster (C19MC) and enrichment of pluripotency factor LIN28A. Here we investigated C19MC oncogenic mechanisms and discovered a C19MC-LIN28A-MYCN circuit fueled by multiple complex regulatory loops including an MYCN core transcriptional network and super-enhancers resulting from long-range MYCN DNA interactions and C19MC gene fusions. Our data show that this powerful oncogenic circuit, which entraps an early neural lineage network, is potently abrogated by bromodomain inhibitor JQ1, leading to ETMR cell death. Sin-Chan et al. uncover a C19MC-LIN28A-MYCN super-enhancer-dependent oncogenic circuit in embryonal tumors with multilayered rosettes (ETMRs). The circuit entraps an early neural lineage network to sustain embryonic epigenetic programming and is vulnerable to bromodomain inhibition, which promotes ETMR cell death.
Lingua originaleEnglish
pagine (da-a)51-67.e7
RivistaCancer Cell
Volume36
DOI
Stato di pubblicazionePubblicato - 2019

Keywords

  • Biomarkers, Tumor
  • Brain Neoplasms
  • C19MC
  • Cell Cycle
  • Cell Transformation, Neoplastic
  • Chromosomes, Human, Pair 19
  • Chromosomes, Human, Pair 2
  • DNA Copy Number Variations
  • ETMR
  • Enhancer Elements, Genetic
  • Epigenesis, Genetic
  • Gene Expression Regulation
  • Gene Regulatory Networks
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Humans
  • LIN28A
  • MYCN
  • MicroRNAs
  • Models, Biological
  • Multigene Family
  • N-Myc Proto-Oncogene Protein
  • Neoplasms, Germ Cell and Embryonal
  • Oncogenes
  • RNA-Binding Proteins
  • brain tumor
  • cell-cycle
  • epigenetics
  • microRNA
  • super-enhancer
  • therapeutics

Fingerprint Entra nei temi di ricerca di 'A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor'. Insieme formano una fingerprint unica.

Cita questo